These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8888233
1. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C. Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233 [Abstract] [Full Text] [Related]
7. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy. Chu WC, Chik KW, Chan YL, Yeung DK, Roebuck DJ, Howard RG, Li CK, Metreweli C. Radiology; 2003 Dec; 229(3):659-69. PubMed ID: 14576448 [Abstract] [Full Text] [Related]
8. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [Abstract] [Full Text] [Related]
9. The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy. Pietz J, Kreis R, Boesch C, Penzien J, Rating D, Herschkowitz N. Pediatr Res; 1995 Nov; 38(5):657-63. PubMed ID: 8552430 [Abstract] [Full Text] [Related]
11. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R. Magn Reson Med; 2007 Dec; 58(6):1145-56. PubMed ID: 18046700 [Abstract] [Full Text] [Related]
12. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. Möller HE, Weglage J, Wiedermann D, Ullrich K. J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507 [Abstract] [Full Text] [Related]
13. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria. Leuzzi V, Bianchi MC, Tosetti M, Carducci CL, Carducci CA, Antonozzi I. J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331 [Abstract] [Full Text] [Related]
14. Neuropsychologic correlates of brain white matter lesions depicted on MR images: 1921 Aberdeen Birth Cohort. Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, Crawford JR, Whalley LJ. Radiology; 2001 Oct; 221(1):51-5. PubMed ID: 11568320 [Abstract] [Full Text] [Related]
15. [Magnetic resonance imaging of the brain in phenylketonuria]. Izumi M, Yamazaki H, Nakabayashi H, Owada M. No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793 [Abstract] [Full Text] [Related]
16. White matter pathology in phenylketonuria. Anderson PJ, Leuzzi V. Mol Genet Metab; 2010 Jan; 99 Suppl 1():S3-9. PubMed ID: 20123467 [Abstract] [Full Text] [Related]
17. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Mastrangelo M, Chiarotti F, Berillo L, Caputi C, Carducci C, Di Biasi C, Manti F, Nardecchia F, Leuzzi V. Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467 [Abstract] [Full Text] [Related]
18. Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Scarabino T, Popolizio T, Tosetti M, Montanaro D, Giannatempo GM, Terlizzi R, Pollice S, Maiorana A, Maggialetti N, Carriero A, Leuzzi V, Salvolini U. Radiol Med; 2009 Apr; 114(3):461-74. PubMed ID: 19277839 [Abstract] [Full Text] [Related]
19. Magnetic resonance imaging of the brain in phenylketonuria. Cleary MA, Walter JH, Wraith JE, Jenkins JP, Alani SM, Tyler K, Whittle D. Lancet; 1994 Jul 09; 344(8915):87-90. PubMed ID: 7912392 [Abstract] [Full Text] [Related]
20. [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients]. Gutiérrez-Mata AP, Vilaseca MA, Capdevila-Cirera A, Vidal-Oller M, Alonso-Colmenero I, Colomé R, López-Sala A, Lambruschini-Ferri N, Gutiérrez A, Gassió R, Artuch R, Campistol J. Rev Neurol; 2012 Aug 16; 55(4):200-6. PubMed ID: 22829083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]